Futura Medical (LON:FUM) Issues Earnings Results

Futura Medical (LON:FUM) released its earnings results on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative return on equity of 152.42% and a negative net margin of 158.21%.

Futura Medical Stock Performance

Shares of FUM remained flat at GBX 0.28 during trading hours on Friday. 8,514,553 shares of the company were exchanged, compared to its average volume of 9,210,257. The company has a market cap of £1.62 million, a P/E ratio of -0.10 and a beta of 0.02. The company’s 50 day moving average is GBX 0.41 and its 200-day moving average is GBX 0.78. Futura Medical has a 1-year low of GBX 0.20 and a 1-year high of GBX 10.45.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.